Covovax
Dec 18, 2021
The World Health Organization has authorised the emergency use listing of Covid vaccine Covovax, which is developed by the Serum Institute of India under licence from Novavax and is part of the Covax...
Jun 16, 2021
The COVID-19 vaccine 'Covovax' is nearing the end of its clinical testing in India, and the Serum Institute of India (SII) aims to commercialize it by September, according to its CEO, Adar Poonawalla.
